Welcome to our dedicated page for Predictmedix news (Ticker: PMEDF), a resource for investors and traders seeking the latest updates and insights on Predictmedix stock.
Predictmedix Inc. (PMEDF) delivers AI-driven health screening solutions for global safety challenges. This page provides investors and stakeholders with official news updates on technological advancements, strategic partnerships, and operational developments.
Access real-time updates on AI health screening innovations, including deployments in healthcare, aviation, and government sectors. Track announcements related to Safe Entry Stations, regulatory milestones, and financial performance.
Users can expect verified updates on multispectral imaging breakthroughs, government contract awards, and expansion into new markets. All content is sourced directly from company filings and authorized communications.
Bookmark this page for streamlined access to Predictmedix's evolving role in non-invasive health monitoring technology. Check regularly for developments impacting public health infrastructure and workplace safety standards.
Predictmedix Inc. (CSE:PMED) has expanded its SAFE ENTRY program through a partnership with SBL Testing Technologies Inc. This collaboration targets North America and the Caribbean, utilizing Predictmedix's AI-powered screening technology to identify infectious disease symptoms and impairments from THC and alcohol.
The SAFE ENTRY Stations offer autonomous, non-invasive screening, with a patent pending in North America. The partnership is positioned to enhance workplace safety amidst the ongoing COVID-19 pandemic and future public health challenges.
Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) is deploying Safe Entry Stations at the Lavazza Drive-In Film Festival in Ontario from June 27 to July 17, 2021. This initiative aims to enhance safety by screening staff and attendees for infectious diseases, including COVID-19, using a rapid AI algorithm. This deployment signifies Predictmedix's expansion into the event industry, following previous implementations at the Super Bowl and HockeyFest. The festival seeks to reconnect communities through a diverse film program, welcoming over 20,000 attendees last year.
Predictmedix Inc. (OTCQB: PMEDF) announces the deployment of its Safe Entry Station units at HockeyFest 2021, North America's largest street and pond hockey festival, starting June 25 in London, Ontario. The partnership with Juiceworks Exhibits and Jones Entertainment Group aims to enhance participant safety through AI-powered screenings for COVID-19 symptoms at events in nine cities. The deployment marks Predictmedix's second venture in live events, highlighting its commitment to provide innovative health solutions to ensure player and spectator safety amid the pandemic.
Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) has launched Safe Entry Stations at Aster Garden Optima Living Community, marking its entry into the North American assisted living market. These AI-powered stations are intended to enhance safety for residents, particularly amid COVID-19. Aster Gardens, which opened on March 21, 2021, aims to provide a secure environment for elderly residents. This initiative involves partnerships with Optima Living, Connectus Global, and Juiceworks Exhibits, showcasing a commitment to leveraging technology in healthcare and community safety.
Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) has deployed Safe Entry Stations at four office towers in Calgary and Edmonton, marking a significant move in partnership with Aspen Properties and Juiceworks. This 24-month contract allows for voluntary, AI-driven screening of infectious disease symptoms, including COVID-19, using non-invasive technology. The initiative aims to enhance safety in shared spaces, showcasing Predictmedix's advanced AI capabilities and providing visibility in the commercial real estate sector. The partnership highlights a proactive approach to tenant safety during ongoing health challenges.
Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) has secured a 24-month contract to implement Safe Entry Stations within Flow Water Inc.'s operations in North America. Following a successful pilot test, this expansion will enhance health and safety protocols across Flow's facilities, significantly reducing absenteeism and improving employee security. The AI-driven technology, designed by infectious disease experts, quickly screens for COVID-19 symptoms, reinforcing Predictmedix's commitment to innovative health solutions amidst ongoing pandemic challenges.
Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) has announced a partnership with JUICEWORKS EXHIBITS and CONNECTUS Global to deploy Safe Entry Stations, utilizing AI technology for assessing symptoms associated with infectious diseases like COVID-19. This innovative technology is designed to enhance safety in shared spaces, contributing to a return to normalcy in the community. The customizable Safe Entry Stations can be implemented in various settings, reflecting a significant advancement in health screening.
Predictmedix has appointed Kingswood Capital Markets to facilitate its potential NASDAQ listing under the symbol PMEDF. This move aims to enhance liquidity and capital market exposure. The listing application is subject to various regulatory requirements, including market maker retention and SEC registration. While this uplisting could significantly support Predictmedix's AI healthcare initiatives, there is no guarantee of NASDAQ acceptance. The company is dedicated to developing non-invasive AI tools for detecting impairment and screening for infectious diseases.
Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) has announced a letter of intent to acquire Symp2Pass Inc. for approximately $5 million. The acquisition aims to enhance Predictmedix's AI-powered health screening solutions, capitalizing on Symp2Pass's strong revenue generation of $2.27 million in 2020. Predictmedix expects this strategic move will broaden its market reach, improve data collection, and increase revenue through innovative product integration. The acquisition is subject to customary closing conditions and expected to finalize within 30-60 days.
Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) announced closing a non-brokered private placement raising $1,090,085 by issuing 3,114,529 units at $0.35 each. Each unit includes one common share and one warrant with an exercise price of $0.50 for two years. The company is expanding operations in marketing, hiring, and R&D following a successful product deployment at a Superbowl after-party, enhancing visibility. Funds will aid in developing AI tools for health and safety solutions in workplaces, amidst rising demand for infectious disease screening technology.